The Relationship Between Obesity and the Pathogenesis of Non-alcoholic Fatty Liver Disease: A Review of the Literature from 2000-2010

Abstract

Introduction: The first decade of the 21st century saw a dramatic rise in the global prevalence of obesity. Coinciding with this epidemic was the recognition of Non-alcoholic Fatty Liver Disease (NAFLD) as a leading cause of chronic liver injury worldwide. This review aims to synthesise the key scientific literature published between 2000 and 2010 that elucidated the critical relationship between obesity and the pathogenesis of NAFLD.

Literature Review: Research during this period firmly established obesity, and its associated insulin resistance, as the principal driver of NAFLD. The "two-hit" hypothesis emerged as the dominant explanatory model. The "first hit" was defined as hepatic steatosis, resulting from increased fatty acid flux to the liver driven by insulin resistance. The "second hit," which promotes progression to the more severe Non-alcoholic Steatohepatitis (NASH), was attributed to factors like oxidative stress, mitochondrial dysfunction, and pro-inflammatory cytokines. Crucially, studies in this era redefined adipose tissue as an active endocrine organ. The roles of adipokines, such as the pro-inflammatory effects of leptin resistance and the loss of the protective, insulin-sensitising effects of adiponectin, were identified as key links between excess adiposity and liver inflammation and fibrosis.

Conclusion: The body of evidence from 2000-2010 solidified the conceptual framework viewing NAFLD as the hepatic manifestation of the metabolic syndrome. It confirmed that obesity, through the mechanism of insulin resistance and a dysregulated adipokine profile, is the primary catalyst for both the development of hepatic steatosis and its inflammatory progression to NASH.